Athira Pharma, Inc. (ATHA) - Quarterly Income Statement

Home
ATHA
Financials

0.3023 (USD) • At close June 3, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	0	0	0	1.656	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0	0.242	0.242	0.245	0.244	0.297	0.287	0.288	0.293	0.268	0.199	0.126	0.123	0.118	0.112	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0	0	-0.242	-0.242	1.411	-0.244	-0.297	-0.287	-0.288	-0.293	-0.268	-0.199	-0.126	-0.123	-0.118	-0.112	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0.852	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	4.302	9.37	17.922	21.912	20.994	23.435	27.202	21.615	21.293	15.236	16.965	14.803	14.46	12.618	10.707	12.024	7.445	5.187	5.83	1.677	0.592	0.658	1.026	1.055	1.055
General & Administrative Expenses Numbers are in millions	5.234	6.196	7.572	5.874	6.451	6.962	7.84	10.025	8.477	7.691	7.168	8.766	8.927	6.16	7.119	4.613	3.336	3.892	1.567	0.575	0.675	0.459	0.509	0.344	0.344
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	5.234	6.196	7.572	5.874	6.451	6.962	7.84	10.025	8.477	7.691	7.168	8.766	8.927	6.16	7.119	4.613	3.336	3.892	1.567	0.575	0.675	0.459	0.509	0.344	0.344
Other Expenses Numbers are in millions	0	0	4.127	1.169	1.35	1.729	2.072	2.043	-0.157	-1.227	-2.959	0.493	-2.234	6.499	-2.079	-2.589	-1.831	-0.817	-1.059	-0.108	0.097	-0.049	-0.021	0	0
Operating Expenses Numbers are in millions	9.536	15.566	29.621	27.786	27.445	30.397	35.042	31.64	29.613	21.7	21.174	24.828	21.153	16.442	15.747	14.048	8.95	7.78	7.397	2.252	1.245	0.835	1.346	1.276	1.276
Operating Income Numbers are in millions	-9.536	-15.566	-29.621	-28.028	-27.687	-30.642	-35.042	-31.64	-29.77	-32.927	-24.133	-23.569	-23.387	-18.778	-17.826	-16.637	-10.781	-9.079	-7.397	-2.252	-1.267	-1.117	-1.535	-1.399	-1.399
Operating Income Ratio Numbers are in millions	0	0	0	0	0	-18.504	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0.393	0.563	0.88	1.169	1.35	1.729	2.072	2.043	1.95	2.792	3.944	-0.766	2.407	2.439	2.152	2.663	1.915	1.377	-1.059	0.26	-0.538	0.143	0.005	0.07	0.07
Income Before Tax Numbers are in millions	-9.143	-15.003	-28.741	-26.859	-26.337	-27.285	-32.97	-29.597	-27.82	-30.135	-20.189	-24.335	-20.98	-16.339	-15.674	-13.974	-8.866	-7.702	-8.456	-1.992	-1.805	-0.974	-1.53	-1.329	-1.329
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	-16.476	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0	0.199	2.194	-0.244	0.122	-1.95	-4.433	-3.944	-0.047	-2.407	1.978	2.153	2.589	1.915	0.421	-0.001	0.144	0.19	-0.179	-0.103	0.07	0.07
Net Income Numbers are in millions	-9.143	-15.003	-28.741	-26.859	-26.337	-27.285	-32.97	-29.597	-25.87	-25.702	-16.245	-24.335	-18.573	-16.339	-15.674	-13.974	-8.866	-7.702	-8.456	-1.992	-1.805	-0.974	-1.53	-1.329	-1.329
Net Income Ratio Numbers are in millions	0	0	0	0	0	-16.476	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.23	-0.39	-0.75	-0.7	-0.69	-0.72	-0.87	-0.78	-0.68	-0.68	-0.43	-0.65	-0.49	-0.44	-0.42	-0.38	-0.25	-0.24	-0.27	-0.061	-0.055	-0.03	-0.049	-0.37	-0.37
EPS Diluted Numbers are in millions	-0.23	-0.39	-0.75	-0.7	-0.69	-0.72	-0.87	-0.78	-0.68	-0.68	-0.43	-0.65	-0.49	-0.44	-0.42	-0.38	-0.25	-0.24	-0.27	-0.061	-0.055	-0.03	-0.049	-0.37	-0.37
EBITDA Numbers are in millions	-9.536	-15.323	-25.251	-27.786	-27.445	-30.397	-34.798	-31.396	-29.534	-22.688	-19.896	-24.067	-20.781	-16.211	-15.55	-13.856	-8.754	-9.079	-8.456	-1.844	-1.587	-0.877	0	0	0
EBITDA Ratio Numbers are in millions	0	0	0	0	0	-18.356	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Athira Pharma, Inc.

NASDAQ:ATHA Add to watchlist

NASDAQ:ATHA